Fortress Biotech Inc.

10/25/2021 | Press release | Distributed by Public on 10/25/2021 05:08

Avenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs